|Articles|April 2, 2019
- Pharmaceutical Technology-04-02-2019
- Volume 43
- Issue 4
Pharmaceutical Technology North America, April 2019 (PDF)
Click the title above to open the Pharmaceutical Technology April 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 7 years ago
Cleaning Chromatography Resin Residues from Surfacesover 7 years ago
OSD Continuous Manufacturing Strategiesover 7 years ago
Channeling Customer Complaints into Qualityover 7 years ago
Continuous Manufacturing Gains Major Push from FDAover 7 years ago
Particles on Best Behaviorover 7 years ago
Spray Drying: Supporting Patient-Centric Drug Developmentover 7 years ago
Advanced Cell Penetrating Peptide Systems for Gene Therapyover 7 years ago
Degradation Pathways: A Case Study with Pegylated L-Asparaginaseover 7 years ago
Locking Fraudulent Materials Out of the Supply ChainAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
What Novartis's $3.2 Billion Enzyme Licensing Deal Means for Formulation
2
CAR T-Cell Trial Pause Signals New Manufacturing Risk Review
3
AAPS PharmSci 360: Microstructure Intelligence in Predictive Drug Development, Part 1
4
AAPS PharmSci 360: CMC Strategies, Part 1
5
